Results 251 to 260 of about 333,295 (341)
Acta Anaesthesiologica Scandinavica, Volume 69, Issue 9, October 2025.ABSTRACT Background Major haemorrhage remains one of the most preventable causes of early death in prehospital care. While prehospital administration of plasma has shown potential to improve survival, logistical challenges limit its use outside hospitals. Dried plasma offers a practical solution, particularly in rural or remote environments.
G. Skallsjö +3 more
wiley +1 more source
Post‐Viral Acquired Idiopathic Purpura Fulminans Caused by Anti‐Protein S Antibodies
Acta Paediatrica, Volume 114, Issue 10, Page 2511-2517, October 2025.ABSTRACT Acquired Idiopathic purpura fulminans is a rare pathology caused by anti‐protein S antibodies. We have conducted a literature review focusing on the most recent developments in diagnosis and management. Diagnosis is based on the demonstration of typical necrotic purpura lesions on the legs. Treatment must be initiated without delay by infusion
Alexandre Theron +2 more
wiley +1 more source
2025 ACVIM Forum Research Abstract Program
Journal of Veterinary Internal Medicine, Volume 39, Issue 6, November/December 2025.
wiley +1 more source
The preoperative coagulation pattern in liver transplant patients [PDF]
, 1986 Bontempo, FA +3 more
core
Higher plasma dicarbonyl levels are associated with liver fibrosis in obese individuals
Diabetes, Obesity and Metabolism, Volume 27, Issue 10, Page 5878-5888, October 2025.Abstract Introduction Methylglyoxal (MGO) is a very reactive compound that modifies proteins, forming advanced glycation end products (AGEs) and activating inflammatory pathways. Elevated MGO levels have been linked to various diseases, including type 2 diabetes and atherosclerosis. However, the role of MGO and other glycating agents in the progression
Oluwatomisono I. Akinrimisi +12 more
wiley +1 more source
International Journal of Laboratory Hematology, Volume 47, Issue 5, Page 923-930, October 2025.ABSTRACT Introduction Argatroban is routinely monitored using activated partial thromboplastin time (APTT), with a recommended target range of 1.5–3.0 times. Although this range was established based on clinical trial data, including several APTT reagents, the differences in reactivity among APTT reagents remain unclear.
Osamu Kumano +6 more
wiley +1 more source
High‐Dose Phenprocoumon Intoxication Treated With Therapeutic Plasma Exchange
Journal of Clinical Apheresis, Volume 40, Issue 5, October 2025.
Lea U. Krauß +6 more
wiley +1 more source
Liver International, Volume 45, Issue 10, October 2025.ABSTRACT Background Clinical trials suggest GLP‐1 receptor agonists (RAs) and dual glucagon‐like peptide‐1 (GLP‐1)/glucose‐dependent insulinotropic polypeptide (GIP) RAs improve metabolic dysfunction associated with steatohepatitis (MASH) in patients with metabolic dysfunction‐associated steatotic liver disease (MASLD). We aimed to compare the estimate
Alex E. Henney +5 more
wiley +1 more source
Characterization and management of patients with hereditary factor X deficiency: A case series
Transfusion, Volume 65, Issue 10, Page 1786-1792, October 2025.Abstract Background Hereditary factor X deficiency (HFXD) is an ultra‐rare, autosomal recessive bleeding disorder that results in reduced factor X coagulant activity (FX:C). HFXD is traditionally classified by severity as severe (FX:C <1%), moderate (FX:C = 1%–5%), or mild (FX:C = 6%–10%).
Meera Chitlur +4 more
wiley +1 more source